79°

Study: AstraZeneca COVID-19 drug neutralizes Omicron sub-variants

The study says the antibody-based cocktail limited inflammation in the lungs, a critical disease site for severe COVID-19.

More Stories

Hometown Heroes in New York City

Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19

00:21

Biden administration announces $600M to produce COVID tests and will reopen website to order them

01:54

Hochul: Updated COVID vaccine to be available in NY in the coming days

02:22

New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution

02:39

City health officials: COVID-19 cases on the rise as new variant emerges